A prospective study of serum amyloid A in relation to plasma administration in neonatal foals.

The research article presents a prospective study on serum amyloid A (SAA) levels in neonatal foals after they have been administered plasma, and the implications those levels may have for diagnosing sick foals.

Objective of the Research

• The research was aimed at studying the levels of SAA, a marker for acute inflammation, in neonatal foals who had been administered prophylactic plasma. This study is critical because plasma administration is common in large breeding farms, and though SAA is used to diagnose acute inflammation, little information exists on the values of SAA in neonatal foals following plasma administration. Thus, understanding these values could improve veterinary practices.

Methodology

• The researchers proceeded with a year-long prospective study involving 31 foals from a veterinary hospital in Texas. All the foals were part of a foaling program, with each one receiving prophylactic plasma 12 hours after its birth.
• The researchers collected blood samples from the foals at various intervals–at birth, 12 hours (pre-plasma), 13 hours (post-plasma), 24 hours, 48 hours, 72 hours, and 96 hours–to measure the SAA levels.

Findings

• Among the 31 foals, eight were clinically ill before plasma administration, while 23 were clinically normal.
• The average SAA value was 1 μg/mL at birth, which increased to 11 μg/mL by the 12th hour (pre-plasma). After plasma administration (13th hour), the SAA value saw a substantial rise to 155 μg/mL.
• About 65% of the foals deemed normal and 63% of those declared ill had an SAA value exceeding 100 μg/mL by the 13th hour.
• The study concluded that there is a frequent but transient rise in SAA levels following plasma administration, which veterinarians should consider when diagnosing clinical illnesses in neonatal foals.